SCHEMBL20015949

SCHEMBL20015949

CCCCc1cc(C(=O)O)n(-c2ccc(N(C)C)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.44
▸ CNR1 P21554 1/20 0.42
▸ CNR2 P34972 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.40
▸ GAA P10253 1/20 0.40
▸ GRN P28799 1/20 0.39
▸ SORT1 Q99523 1/20 0.39
▸ LMNA P02545 2/20 0.38
▸ KDM5A P29375 1/20 0.38
▸ KDM4C Q9H3R0 1/20 0.38
▸ KDM5B Q9UGL1 1/20 0.38
▸ RXRA P19793 4/20 0.37
▸ RXRB P28702 4/20 0.37
▸ RXRG P48443 4/20 0.37
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ RECQL P46063 2/20 0.36
▸ CTDSP1 Q9GZU7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18277670 0.78 RPA1 (0.46) ALOX5CNR1CNR2ALDH1A1GAA
SCHEMBL27795107 0.77 ALDH1A1 (0.59) ALOX5CNR1CNR2ALDH1A1GAA
SCHEMBL19101969 0.77 ALDH1A1 (0.47) ALDH1A1GAAGRNSORT1KDM5A
SCHEMBL27889993 0.77 HTT (0.51) ALOX5CNR1CNR2ALDH1A1GAA
SCHEMBL3831066 0.74 NOTUM (0.43) ALOX5CNR1CNR2ALDH1A1GAA
SCHEMBL15485403 0.74 GRN (0.72) ALDH1A1GAAGRNSORT1LMNA
SCHEMBL17369126 0.73 ALDH1A1 (0.59) CNR1CNR2ALDH1A1GAAGRN
SCHEMBL9468599 0.72 KDM5A (0.43) ALOX5CNR1CNR2ALDH1A1GRN
SCHEMBL2934234 0.72 KDM4E (0.47) ALDH1A1GAAGRNSORT1LMNA
SCHEMBL19388963 0.72 PTGS1 (0.48) ALOX5CNR1CNR2KDM5AKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301288-B2 Kinase inhibitors TOPIVERT PHARMA LIMITED (GB) 2019-05-28 — — US disclosed
US-20180086741-A1 KINASE INHIBITORS OXULAR ACQUISITIONS LIMITED (GB) 2018-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086741-A1 KINASE INHIBITORS SYK, BTK, SRC ALOX5 2655/4885CNR1 3571/4885CNR2 3280/4885
US-10301288-B2 Kinase inhibitors SYK, BTK, SRC ALOX5 2655/4885CNR1 3571/4885CNR2 3280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback